Inflammatory bowel disease (IBD) is a chronic disease that affects millions of people worldwide.
Inflammatory bowel disease (IBD) remains an important area of research in immunology and gastroenterology.
Inflammatory bowel disease (IBD) has become a major global health problem and is characterized by chronic inflammation of the gastrointestinal tract.
Colitis is a common and often debilitating form of inflammatory bowel disease (IBD), affecting millions of people worldwide. Researchers and healthcare professionals continue to seek new ways to better understand, diagnose and treat this chronic disease. One of the keys to improving treatment strategies is the development and use of IBD models.
Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, affects millions of people worldwide and remains one of the most challenging chronic inflammatory diseases. The underlying causes of IBD are complex and involve genetic predispositions, immune system dysfunction, and environmental factors.
Colitis is an inflammatory bowel disease (IBD) that poses significant challenges to medical research and patient care. This chronic disease causes inflammation of the colon, leading to symptoms such as abdominal pain, diarrhea, fatigue, and even life-threatening complications.